Related Experiment Video
Updated: Aug 3, 2026

Determining the Reactivity and Titre of Serum using a Haemagglutination Assay
Published on: January 29, 2010
A clinical evaluation of a card agglutination test for rheumatoid factor
Insights
The Macro-Vue Card Test for Rheumatoid Factor offers reproducible results and detects more positive sera compared to other commercial kits. This rheumatoid factor test provides reliable qualitative and quantitative analysis for patient diagnosis.
Area of Science:
- Immunology
- Clinical Chemistry
- Diagnostic Assays
Background:
- Rheumatoid factor (RF) is a key biomarker in diagnosing rheumatoid arthritis.
- Accurate and reproducible RF detection is crucial for effective patient management.
- Evaluating new diagnostic tools is essential for improving laboratory diagnostics.
Purpose of the Study:
- To evaluate the performance of the new Hynson, Westcott, and Dunning Macro-Vue Card Test for Rheumatoid Factor.
- To compare the Macro-Vue test with other commercially available rheumatoid factor assays.
- To assess the qualitative and quantitative capabilities of the Macro-Vue RF Card Test.
Main Methods:
- A comparative study was conducted using coded sera from 195 patients.
- Four commercial rheumatoid factor kits were evaluated: Hyland RA Test (latex), Behring-Rapi/tex RF Test (latex), Wampole Rheumaton (sheep erythrocytes), and HWD-Macro-Vue RF Card Test (charcoal).
- Qualitative and quantitative analyses were performed according to manufacturers' instructions, with reproducibility assessed using known positive sera.
Main Results:
- The Macro-Vue RF Card Test demonstrated comparable performance to latex-based systems (Behring and Hyland).
- The Macro-Vue test identified a higher percentage of positive sera than the Wampole test.
- Titers determined by the Macro-Vue test showed superior day-to-day reproducibility compared to all other evaluated kits.
Conclusions:
- The Macro-Vue Card Test for Rheumatoid Factor is a reliable diagnostic tool for both qualitative and quantitative RF detection.
- Its high reproducibility makes it a valuable option for clinical laboratories seeking consistent rheumatoid factor testing.
- The Macro-Vue test offers a competitive alternative to existing commercial rheumatoid factor assays, particularly in terms of titer stability.
Abstract:
The Macro-Vue Card Test for Rheumatoid Factor (Hynson, Westcott, and Dunning) is a new commercially available card agglutination test designed for qualitative and quantitative procedures. Coded sera from 195 patients, six known positive sera, and two positive serum pools were tested using four commercial kits. The commercial kits evaluated included latex (Hyland RA Test, Behring-Rapi/tex RF Test), sheep erythrocytes (Wampole, Rheumaton), and charcoal (HWD-Macro-Vue RF Card Test) as carrier particles. Using the prescribed quantitative procedures, the percentages of positive and negative results for rheumatoid factor detected by each product were determined after the (serum) code was broken. The Macro-Vue test compares well with the Behring and Hyland latex dilution systems, and appears to detect more positive sera than the Wampole test. Titers obtained using the Macro-Vue test were more reproducible day to day with known positive sera than were titers obtained using any of the other kits.
More Related Videos
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Dysrhythmias V: Evaluating Dysrhythmias